Skip to Main Content

Issues

ISSN 0143-5221
EISSN 1470-8736
In this Issue

Review Articles

Clinical Science (15 September 2017) 131 (18): 2319–2345.

Commentaries

Clinical Science (15 September 2017) 131 (18): 2377–2379.

Research Articles

Clinical Science (15 September 2017) 131 (18): 2347–2362.
Clinical Science (15 September 2017) 131 (18): 2363–2375.
Clinical Science (15 September 2017) 131 (18): 2381–2395.
Clinical Science (15 September 2017) 131 (18): 2397–2408.
  • Cover Image

    Cover Image

    issue cover
    A flurogold labeled-retina flatmount (front) representing surviving retinal ganglion cells, and the chemical structure of trimetazidine (background). In Clinical Science volume 131, issue 18, Wan et al. report that trimetazidine protects retinal ganglion cells against acute glaucoma via the Nrf2/Ho-1 pathway and propose it as a novel therapeutic agent; for details, see pages 2363-2375.
Close Modal
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close Modal
Close Modal